ArticleGland surgery2025

The development and validation of biomarkers-based scoring systems for predicting early recurrence in patients with borderline resectable pancreatic cancer undergoing resection after neoadjuvant therapy.

Hang He et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.